Your browser doesn't support javascript.
loading
Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult.
Ziaei, Amin; Garcia-Miralles, Marta; Radulescu, Carola I; Sidik, Harwin; Silvin, Aymeric; Bae, Han-Gyu; Bonnard, Carine; Yusof, Nur Amirah Binte Mohammad; Ferrari Bardile, Costanza; Tan, Liang Juin; Ng, Alvin Yu Jin; Tohari, Sumanty; Dehghani, Leila; Henry, Lily; Yeo, Xin Yi; Lee, Sejin; Venkatesh, Byrappa; Langley, Sarah R; Shaygannejad, Vahid; Reversade, Bruno; Jung, Sangyong; Ginhoux, Florent; Pouladi, Mahmoud A.
Afiliação
  • Ziaei A; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Garcia-Miralles M; UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
  • Radulescu CI; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Sidik H; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Silvin A; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Bae HG; Singapore Immunology Network (SIgN), A*STAR, Singapore, Singapore.
  • Bonnard C; Institute of Molecular and Cell Biology, A*STAR, Biopolis, Singapore, Singapore.
  • Yusof NABM; Department of Life Sciences, Yeungnam University, Gyeongsan, South Korea.
  • Ferrari Bardile C; Institute of Medical Biology, A*STAR, Singapore, Singapore.
  • Tan LJ; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Ng AYJ; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Tohari S; Department of Medical Genetics, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Dehghani L; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Henry L; Institute of Molecular and Cell Biology, A*STAR, Biopolis, Singapore, Singapore.
  • Yeo XY; Institute of Molecular and Cell Biology, A*STAR, Biopolis, Singapore, Singapore.
  • Lee S; Department of Neurology, Isfahan Neurosciences Research Centre, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Venkatesh B; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.
  • Langley SR; Institute of Molecular and Cell Biology, A*STAR, Biopolis, Singapore, Singapore.
  • Shaygannejad V; Institute of Molecular and Cell Biology, A*STAR, Biopolis, Singapore, Singapore.
  • Reversade B; Institute of Molecular and Cell Biology, A*STAR, Biopolis, Singapore, Singapore.
  • Jung S; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Ginhoux F; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Pouladi MA; Department of Neurology, Isfahan Neurosciences Research Centre, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Brain Pathol ; 32(5): e13064, 2022 09.
Article em En | MEDLINE | ID: mdl-35285112

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article